GSK2793660 HCl manufacturers
- GSK2793660 HCl
-
- $2500.00
-
2026-07-15
- CAS:1613458-79-9
- Purity:
- Supply Ability: 10g
|
| | GSK2793660 HCl Basic information |
| Product Name: | GSK2793660 HCl | | Synonyms: | GSK2793660 HCl;GSK 2793660
(GSK2793660;GSK-2793660 HCl,GSK2793660 HCl;Propyl-GSK-2793660 hydrochloride | | CAS: | 1613458-79-9 | | MF: | C22H32ClN3O3 | | MW: | 421.97 | | EINECS: | | | Product Categories: | | | Mol File: | 1613458-79-9.mol |  |
| | GSK2793660 HCl Chemical Properties |
| | GSK2793660 HCl Usage And Synthesis |
| Description | GSK2793660 is a irreversible covalent α,β-unsaturated amide based DPP1 inhibitor currently in clinical trials for the treatment of cystic fibrosis, noncystic fibrosis bronchiectasis, ANCA-associated vasculitis and bronchiectasis. | | Uses | GSK2793660 hydrochloride is an orally active, irreversible cathepsin C (CTSC) inhibitor for bronchodilation studies[1]. | | References | [1] Bruce E Miller, et al. Epithelial desquamation observed in a phase I study of an oral cathepsin C inhibitor (GSK2793660). Br J Clin Pharmacol. 2017 Dec;83(12):2813-2820. DOI:10.1111/bcp.13398 |
| | GSK2793660 HCl Preparation Products And Raw materials |
|